Literature DB >> 2505624

A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.

M Tanaka1, H Ohmae, H Utsunomiya, T Nara, Y Irie, K Yasuraoka.   

Abstract

Praziquantel (PZQ) is a racemic compound composed of equal proportions of its optical isomers, levo- and dextro-PZQ. The efficacy of these compounds was compared with that of PZQ in mice infected with Schistosoma japonicum or S. mansoni. Mice were given 50, 2 x 50 (on consecutive days), 500, or 2 x 250 mg/kg of each compound orally 5 weeks after infection. Significant reduction of worm recovery was observed in S. japonicum infection 30 days after treatment with 2 x 50, 500, or 2 x 250 mg/kg of levo-PZQ, whereas no therapeutic effect was demonstrated with dextro-PZQ. Percent reduction in worm burden in mice treated with levo-PZQ was significantly higher than in those with PZQ at a dosage of 2 x 50 mg/kg (67.9% vs. 34.5%). Neither eggs in feces nor miracidial hatching of eggs from the livers and intestines were observed in mice treated with levo-PZQ. In S. mansoni infection, levo-PZQ showed no significant schistosomicidal effect compared with PZQ and dextro-PZQ, although there was reduction in egg counts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505624     DOI: 10.4269/ajtmh.1989.41.198

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

Review 1.  Schistosomiasis drug therapy and treatment considerations.

Authors:  K C Shekhar
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.

Authors:  Lalit Kumar Sharma; Pauline M Cupit; Tino Goronga; Thomas R Webb; Charles Cunningham
Journal:  Bioorg Med Chem Lett       Date:  2014-04-13       Impact factor: 2.823

3.  Resolution of praziquantel.

Authors:  Michael Woelfle; Jean-Paul Seerden; Jesse de Gooijer; Kees Pouwer; Piero Olliaro; Matthew H Todd
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20

4.  Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.

Authors:  Ravi S Kasinathan; Lalit Kumar Sharma; Charles Cunningham; Thomas R Webb; Robert M Greenberg
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

5.  Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.

Authors:  Isabel Meister; Katrin Ingram-Sieber; Noemi Cowan; Matthew Todd; Murray N Robertson; Claudia Meli; Malay Patra; Gilles Gasser; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

6.  Cocrystals of Praziquantel: Discovery by Network-Based Link Prediction.

Authors:  Jan-Joris Devogelaer; Maxime D Charpentier; Arnoud Tijink; Valérie Dupray; Gérard Coquerel; Karen Johnston; Hugo Meekes; Paul Tinnemans; Elias Vlieg; Joop H Ter Horst; René de Gelder
Journal:  Cryst Growth Des       Date:  2021-05-20       Impact factor: 4.076

7.  Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.

Authors:  Amaya L Bustinduy; David Waterhouse; Jose C de Sousa-Figueiredo; Stephen A Roberts; Aaron Atuhaire; Govert J Van Dam; Paul L A M Corstjens; Janet T Scott; Michelle C Stanton; Narcis B Kabatereine; Stephen Ward; William W Hope; J Russell Stothard
Journal:  mBio       Date:  2016-08-09       Impact factor: 7.867

8.  In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.

Authors:  Jana Kovač; Mireille Vargas; Jennifer Keiser
Journal:  Parasit Vectors       Date:  2017-08-01       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.